Open reading frames (ORFs) upstream of the normal AUG start codon occur only rarely in eukaryotic transcripts (1, 2) and usually have the effect of inhibiting the translation of the normal downstream ORFs (3) . As yet no inherited deficiency of a mammalian enzyme has been attributed to a mutation that produces an upstream ORF. We describe here a naturally occurring base-change mutation that produces an upstream ORF in the erythrocyte CA I mRNA of the pigtail macaque Macaca nemestrina. This mutation results in the reduction (==5000-fold) to trace levels of erythrocyte CA I (4, 5) , suggesting that reinitiation at the normal start site occurs only infrequently, producing the CA I-deficiency phenotype. These findings are in agreement with the scanning model for initiation of translation in eukaryotes. This model has been thoroughly tested by in vitro mutagenesis experiments and predicts that translation will begin at the first AUG codon downstream ofthe cap site that is in a good sequence context; a purine at position -3 from the AUG is usually adequate for initiation (6) (7) (8) .
Eight CA or CA-related genes are known in mammals (cf. refs. 9 and 10). The CA I gene is unique, however, in that it is under the control of two promoter regions (10) (11) (12) . It appears that one promoter is essentially erythrocyte-specific, whereas the other controls CA I expression in the colonic mucosa and probably other tissues that normally express CA I (10, 11, 13) . The erythrocyte CA I deficiency allele we have characterized is common in populations of pigtail macaques from southeast Asia where its frequency ranges from 0.55 in Thailand and 0.57 in Malaysia to 0.70 on the island of Sumatra (4, 14, 15) . The finding of trace levels of CA I in erythrocytes and seemingly normal levels in the colonic mucosa of individuals homozygous for the erythrocyte CA I-deficiency allele suggested that the mutation was located either in an erythroid-specific promoter element or in the untranslated exon la that is unique to the seemingly specific CA I mRNA expressed in erythrocytes (10) (11) (12) Table 1 . The primers were annealed to the template by boiling for 3 min in the presence of 0.5% Nonidet P-40 (16) . The DNA was immediately snap-cooled in a dry-ice/ethanol slurry and then allowed to thaw on wet ice for 10 min. The DNA was then sequenced according to the protocol supplied with the Sequenase kit (United States Biochemical). The sequence is numbered from the translational start site.
Quantification of CA I mRNA. mRNA was quantified according to a modified "PATTY" protocol (17 To analyze the erythroid-specific mRNA (containing exon la), the H-ATGD and stop2u primers were used, and the ATGD and stop2u primers were used for the total level of CA I. In both cases the first PCR was followed by a second hemi-nested amplification with EX6u as the upstream-directed primer. Five units of BamHI were added directly to the PCR mixtures. After 1 h at 370C, 5 ,ul of the reaction mixture was electrophoresed on a 1% agarose gel. Several amplifications were made from different animals to ensure the consistency of the results. In Vitro Translation. The H-ATCD primers were used with the stop primer to amplify cDNA in two separate reaction mixtures (Fig. 2 ). After reamplification with the H-ATCD or H-ATGD and EX6u primers, the reaction products were cut with HindIII and EcoRI and cloned into pBSM13-.
To remove the UAG translational stop codon and to introduce the T3 RNA polymerase promoter upstream of the cap site, the pBSM13-clones were amplified with the M13 rev and 8u primers. In parallel, cDNA was amplified with -22D and stop primers. Portions of the amplified DNA were mixed and amplified with the M13 rev and stop2u primers. (19) . The gel was then dried and exposed to a Kodak XAR film for 3 days.
Determination of the Cap Site. The general method used has been described by Loh et al. (20) . RNA was prepared as described under mRNA quantification. Total RNA (10 ;.g) was reversed-transcribed into single-stranded cDNA, which was dG-tailed with terminal deoxynucleotidyltransferase in 1 mM dGTP and 0.75 mM CoCl2 (21) . The dG-tailed cDNA was used as template in a PCR with the anchorCD and stop primers. The reaction was reamplified with the anchor and EX6u primers. To specifically amplify the erythrocyte CA I mRNA, a second reamplification with the anchorD and eryu primers was performed. The PCR product of the latter FIG. 2. Preparation of constructs for mRNA translation. #, T3 RNA polymerase promoter; -stop, construct with the UAG stop codon at positions -9 to -7 mutated to UAC. Two constructs are synthesized with a guanosine or cytidine at position -85. Due to the T3 promoter, the transcribed RNA will have the sequence m7GpppGGGAACAAAA preceding the natural cap site, where m7GpppG is 7-methylguanosine(5')triphospho(5')guanosine.
reaction was purified by PAGE on a 6% gel and sequenced with the eryu primer. Primer extension was performed as described (22) . 32P-labeled eryu primer (1 x 105 dpm) was annealed to 50 pZg of total spleen RNA at 250C overnight.
RESULTS
Characterization of the Mutant CA I. To determine the cause of this erythrocyte-specific deficiency, the PCR methodology was used to amplify and directly sequence the seven coding exons of CA I, the upstream noncoding exon la and the exon-intron boundaries (13, 23) . In this way, we sequenced the CA I genes from a homozygous normal and erythrocyte CA I-deficient animal. The only dfflerence between the normal and the erythrocyte CA I-deficient mRNAs was the presence in the mutant mRNA ofa translational AUG start codon 87 bp upstream of the normal start site (Fig. 3) . The cap site was shown to be 9 bp upstream of the mutant AUG start codon (Fig. 4) . This start codon is in-phase with a UAG stop codon 9 bp upstream from the normal AUG start codon. Because this mutation is present only in the erythrocyte CA I mRNA (Fig. 3) (Fig. 2) used in the in vitro translations (see Fig. 6 ). The mutant and normal AUG start sites are underlined. promoter is used. Exon la was sequenced from two homozygous-deficient, one homozygous-normal, and two heterozygous animals. In all of these cases, a guanosine at position -85 (AUOj) was associated with the deficiency.
Quantitation of CA I mRNA. As shown in Fig. 3 , the CA I mRNA in colon and erythroid cells differ in their 5' untranslated ends due to the use of two different promoters (10) (11) (12) . The levels of CA I mRNA expressed as the relative amounts of the erythroid mRNA/total CA I mRNA were the same in the spleen of normal and erythrocyte CA I-deficient macaques (Fig. 5) .
In Vitro Translation. To prove that the mutant upstream translational start site is used, cDNA sequences from normal and mutant mRNAs were first cloned into pBSM13-, PCRamplified, and then transcribed and translated in vitro (Fig.  6 ). Because the amplified constructs included the T3 promoter and the HindIII site ofpBSM13 -, the transcripts have In vitro translation of CA I mRNAs in reticulocyte lysates with upstream nucleotides at positions -7 to -9 changed from UAG (stop) to UAC (tyrosine). Lanes: 1 (17) . Lanes: 1-8, erythroid-specific CA I mRNA (using an exon la-specific -96D primer); 9-16, total CA I mRNA (using the ATGD and stopu primers common to both erythroid and nonerythroid mRNAs); [1] [2] [3] [4] Comparison of these lanes also shows that almost all of the CA I mRNA in spleen is transcribed from the erythroid-specific promoter. Proc. Nati. Acad. Sci. USA 89 (1992) possible that there may be a low level of expression from the nonerythrocyte (e.g., colon)-specific promoter in CA I-deficient erythrocytes. In this case reinitiation on the erythrocyte-specific mRNA (or direct internal ribosome binding) would be predicted to be even less frequent than 1 in 5000.
Although almost all cellular mRNAs use only one initiation and termination codon, there is now evidence that reinitiation can occur in some mRNAs (3, 26, 27) . In general, the reinitiation is more efficient as the distance increases between the stop codon of the upstream ORF and the normal start site. Thus, the fact that only 6 nucleotides separate the termination of the upstream ORF and the normal AUG initiation further supports our conclusion that the mutation we have described is responsible for the erythrocyte CA I deficiency.
Even though CA I is the second most abundant nonglobin protein in most mammalian erythrocytes [e.g., [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] ,ug/mg of hemoglobulin in pigtail macaques (5)], its virtual absence in erythrocytes does not appear to be associated with any physiological abnormality. Inherited deficiencies of erythrocyte CA I in humans and pigtail macaques exhibit no detectable hematological or other clinical disorders (4, 5, 28, 29) . Furthermore, CA I is characteristically absent in the erythrocytes of all ruminants (e.g., ox, goat, and sheep) and felids (e.g., cat, lion, and tiger) examined to date (cf. ref. 30 ).
An intriguing feature of the CA I deficiency mutation is a related cis-acting reduction of -60% in the levels of the other erythrocyte CA isozyme, CA II, in individuals homozygous for the CA I deficiency (5) . If the order of the CA I, CA II, and CA III genes is the same in pigtail macaques as it is in humans (31) , then the promoter regions of the human CA I and CA II genes are separated by =110 kilobases, with the CA III gene located between them (31) . The basis for what seems to be a secondary effect on the expression of CA II by the CA I mutation would appear to be particularly worthwhile to investigate.
